12-Month Stability of Diurnal IOP Control on Cosopt
NCT00379834
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Glaucoma
Interventions
DRUG:
Cosopt
Sponsor
West Virginia University